Came across this stock at the recent investor presentation in Sydney which got me interested.
Have a few questions.
Are there any competitors?
In the presentation slidepack their schedule for commercial launch (which is upside down btw. Gantt chart should read and cascade from top left to bottom right) they mentioned they are expecting to execute commercial agreements with radiology providers. Would they not need the clinical validation study to be completed before executing contracts?
is the NATA accreditation milestone likely to be price sensitive if successful?
Do they not need TGA CE and FDA approvals?
2.02 quarters of funding available so CR likely in July August time. Clinical studies rarely meet forecast end dates. So on my Watch list for now.
Add to My Watchlist
What is My Watchlist?
